Kunngjøring av tildeling · 22.08.2025

Laboratory, optical and precision equipments (excl. glasses) – 77093 UL KLM Dep. for Medical Biochemistry Analysis Instrument

OSLO UNIVERSITETSSYKEHUS HF i OSLO publiserte denne kunngjøringen i TED 22.08.2025. Oppgitt verdi er 12 000 000 NOK. Kontrakten ble tildelt The Binding Site Danmark Aps.

Type

Kunngjøring av tildeling

Publisert

22.08.2025

Oppdragsgiver

OSLO UNIVERSITETSSYKEHUS HF

Sted

OSLO

Art

Varer

Verdi

12 000 000 NOK

CPV-koder

33000000, 38000000

Leverandør (tildelt)

The Binding Site Danmark Aps

TED-nummer

548750-2025

Beskrivelse

Oslo University Hospital, Department of Medical Biochemistry, Unit for special analyses, shall procure a new analysis instrument. The procured instrument shall mainly be used for analysing free light chains Kappa and Lambda with reagents from The Binding Site. Kappa and lambda shall be measured with immunoturbidimetry. The analysis must cover a very broad concentration area, from 1 mg/L to over 100,000 mg/L. This large variation in concentration makes the analysis exposed to antigene excess problems. To ensure reliable results, it is crucial to have a robust and validated antigen excess system, which requires collaboration between the supplier of reagents and the instrument if these are not the same. Based on the large volume, clinical significance and complexity of the cutting and lambda analyses in relation to kinetics/antigen excess, we believe it is necessary to require an IVDR certified application for analysing the cloak and lambda in serum on the new instrument. In addition a small number of analyses of the erytrocyte enzymes Glucose 6 phosphate dehydrogenase (G6PD), pyruvatkinase (PK) and colinesterase with dibucain inhibition shall also be carried out. The unit for special analyses has a de facto country function for analysing G6PD and PK. The department makes approx. 10,000 analyses per annum and needs a high capacity instrument. Optilite from The Binding Site is the only instrument that can provide the necessary performance for the above mentioned reasons. The terms in PPR § 13-4 (2) are considered fulfilled. Any objections are to be reported to the project manager within 10 days after the published notice.

Les hele kunngjøringen og konkurransegrunnlaget hos TED · Om oppdragsgiveren (org.nr. 993467049)

Andre kunngjøringer fra OSLO UNIVERSITETSSYKEHUS HF

Kilde: TED – Tenders Electronic Daily, Den europeiske unions publikasjonskontor (© EU, gjenbruk tillatt med kildehenvisning). Viser kunngjøringer som er sendt til TED (over EØS-terskelverdiene); mindre anskaffelser finnes på doffin.no. Vi er ikke oppdragsgiver og tar ikke imot tilbud.